September 10, 2026 · 7 min read
Apple Gets Into Longevity. What Happens After the Score?
I’m probably buying the watch. I’m harder to sell on another health score.
Read issueThe CareCore Stack
Archive
Clinical evidence, market structure, and the operating choices shaping care.
September 2, 2026 · 9 min read
Who Decided This Cancer Drug Costs $477,600?
Daraxonrasib is a real pancreatic cancer advance. Its price shows what happens when a company names the starting number and the payer cannot easily walk away.
Read issueJune 26, 2026 · 4 min read
Welcome to The CareCore Stack
A doctor's note on the quest to fix healthcare.
Read issueMay 1, 2026 · 6 min read
Peptides are not the product
Peptides are where longevity medicine's demand curve collides with pharmacy quality, regulatory process, and clinical governance.
Read issue